(Q44405088)

2 December 2017

HIV-1 viral protein R compromises cellular immune function in vivo (English)

1 reference

2 December 2017

1 reference

10

David B Weiner

1 reference

2 December 2017

Velpandi Ayyavoo

1

1 reference

2 December 2017

Karuppiah Muthumani

2

1 reference

2 December 2017

Sagar Kudchodkar

3

1 reference

2 December 2017

Donghui Zhang

4

1 reference

2 December 2017

P Ramanathan

5

1 reference

2 December 2017

Nathanael S Dayes

6

1 reference

2 December 2017

J J Kim

7

1 reference

2 December 2017

Jeong-Im Sin

8

1 reference

2 December 2017

Luis J Montaner

9

1 reference

2 December 2017

1 January 2002

1 reference

2 December 2017

International Immunology

1 reference

2 December 2017

14

1 reference

2 December 2017

13-22

1 reference

2 December 2017

1

1 reference

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

2 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Induction of cell differentiation by human immunodeficiency virus 1 vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

CD8 naive T cell counts decrease progressively in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.13

21 January 2018

Identifiers

DOI

10.1093/INTIMM/14.1.13

1 reference

2 December 2017

1 reference